Overview
Leonardo Zepeda-Meza practices in Oslo, Norway. Mr. Zepeda-Meza is rated as an Advanced expert by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Osteosarcoma, Liposarcoma, and Gastrointestinal Stromal Tumor.
His clinical research consists of co-authoring 77 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Osteosarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult Soft Tissue SarcomaMr. Zepeda-Meza isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Gastrointestinal Stromal TumorMr. Zepeda-Meza isAdvanced. Learn about Gastrointestinal Stromal Tumor.
- LiposarcomaMr. Zepeda-Meza isAdvanced. Learn about Liposarcoma.
- OsteosarcomaMr. Zepeda-Meza isAdvanced. Learn about Osteosarcoma.
- Experienced
- B-Cell LymphomaMr. Zepeda-Meza isExperienced. Learn about B-Cell Lymphoma.
- Bone TumorMr. Zepeda-Meza isExperienced. Learn about Bone Tumor.
- Colorectal CancerMr. Zepeda-Meza isExperienced. Learn about Colorectal Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Zepeda-Meza isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaMr. Zepeda-Meza isExperienced. Learn about Follicular Lymphoma.
- MelanomaMr. Zepeda-Meza isExperienced. Learn about Melanoma.